We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Drug Prescriptions for Children With ADHD in Japan: A Study Based on Health Insurance Claims Data Between 2005 and 2015.
- Authors
Yoshida, Makiko; Obara, Taku; Kikuchi, Saya; Satoh, Michihiro; Morikawa, Yoshihiko; Ooba, Nobuhiro; Yamaguchi, Hiroaki; Mano, Nariyasu
- Abstract
Objective: The aim of this study is to investigate the trend of prescription drugs for children with ADHD in Japan. Method: Using health insurance claims data of 3,672,951 people between January 2005 and December 2015, we investigated the trend of prescription drugs for 7,856 children with ADHD. Results: After approval in 2007, the proportion of prescriptions for methylphenidate-osmotic-controlled release oral delivery system tablets was 31.4% in 2009 (adjusted odds ratio [AOR] = 2.72; 95% confidence interval [CI] = [2.12, 3.51]) and reached a plateau approximately after 2009 (AOR = 0.96; 95% CI = [0.94, 0.98]). The proportion of prescriptions for atomoxetine increased from 6.1% in 2008 to 21.8% in 2014 (AOR = 1.12; 95% CI = [1.13, 1.18]). The proportion of prescriptions for aripiprazole and ramelteon increased (all trend p <.001). Conclusion: Prescriptions of drugs for children with ADHD have changed. We need to monitor the safety of ADHD medications among children with ADHD.
- Subjects
HEALTH insurance; METHYLPHENIDATE; ODDS ratio; DRUG utilization; NARCOLEPSY
- Publication
Journal of Attention Disorders, 2020, Vol 24, Issue 2, p175
- ISSN
1087-0547
- Publication type
Article
- DOI
10.1177/1087054719843179